Aller au contenu principal
Accès ouvert déclaré 2025 article

Responsiveness of the neurodisability scale for meningoencephalitis of unknown origin in dogs

0Citations signalées, ce qui n’est pas une note de qualité
1Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : gb. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Objectives To determine the responsiveness of the neurodisability scale during the treatment of meningoencephalitis of unknown origin in dogs. Materials and Methods The neurodisability scale score was determined at initial presentation and then repeated at each reassessment during treatment. At each visit, a subjective clinical evaluation of the response to treatment was also recorded. Responsiveness of the neurodisability scale between timepoints was evaluated using the receiver operating characteristics method and correlation analysis. Responsiveness was calculated between the neurodisability scale score at initial assessment and the first re‐examination after starting treatment ( T 1 ). It was also calculated between the neurodisability scale score at T 1 and a second reassessment ( T 2 ) where the score had changed either due to relapse or further improvement (if no changes occurred, the last available assessment was used). Results Thirty‐eight dogs were included. Median time between T 0 and T 1 was 3 weeks, and 35/38 had shown clinical improvement. Median time between T 1 and T 2 was 6 months; 13 dogs were suspected to have clinical relapse. The neurodisability scale demonstrated excellent responsiveness at both timepoints, with area under the curves of 0.96 (95% CI = 0.89 to 1) at T 1 and 0.93 (95% CI = 0.85 to 1) at T 2 . There was also an excellent negative correlation coefficient produced by the change in score and the dogs’ subjective clinical evaluation ( T 0 − T 1 Gamma = −0.8 and T 1 − T 2 Gamma = −0.88). Clinical Significance The neurodisability scale is a responsive monitoring tool during meningoencephalitis of unknown origin treatment and relapse. Our results support the utility of the neurodisability scale as a clinician‐reported outcome measure for use in clinical trials.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Responsiveness of the neurodisability scale for meningoencephalitis of unknown origin in dogs
Date Crossref
04/06/2025
Éditeur
Wiley
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • University of Liverpool Department of Small Animal Clinical Science pays non établi dans la notice
    Université ou école supérieure

Department of Small Animal Clinical Science — University of Liverpool.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Herpesvirus Infections and TreatmentsVirology and Viral DiseasesBacterial Infections and Vaccines

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.